Skip to main content
TipRanks
Go Ultimate75% OFF

Julius Knowles Insider Profile

4 Followers

Julius Knowles, Director at Keros Therapeutics, holds 263.24K shares in Keros Therapeutics (Ticker: KROS).

Julius Knowles's Trading History

KROS
Keros Therapeutics
Jun 08, 2026DirectorUninformative Sell28.17K$2.71M
KROS
Insider Shares: 263.24K (1.33%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 08, 2026Uninformative Sell$28.17K2,625$10.73―
Jun 05, 2026Uninformative Buy$0.007,142$0.00―
Dec 18, 2025Uninformative Sell$5.72M322,021$17.75―
Jun 06, 2025Uninformative Buy$0.005,250$0.00―
Jan 20, 2023Informative Buy$24.99K1,191$20.98―

You May Also Like

Julius Knowles insider profile FAQ

What stocks does Julius Knowles hold?
Julius Knowles holds: KROS stocks.
What was Julius Knowles’s latest transaction?
Julius Knowles’s latest transaction was an Uninformative Sell of $28.17K.
What is Julius Knowles's role in Keros Therapeutics?
Julius Knowles's role in Keros Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.